A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III clinical trial to assess the efficacy and safety of Yuping Tongqiao tablets in the treatment of persistent allergic rhinitis
Bibliographic Data
ChiCTR, ChiCTR2200061367. Registered June 22, 2022
Alternative medicine · Clinical trial · Double blind · Multicenter study · Pathology · Placebo · Randomized controlled trial · Allergic Rhinitis and Sensitization · Asthma and respiratory diseases · Dermatology and Skin Diseases · Medicine · Internal Medicine
| Citation velocity | historical |
|---|---|
| Highly cited | No |